COVID-19 pandemic: SARS-CoV-2 specific vaccines and challenges, protection via BCG trained immunity, and clinical trials
Wenping Gong, Ashok Aspatwar, Shuyong Wang, Seppo Parkkila, Xueqiong Wu
Abstract
: The advantages of the BCG vaccine can compensate for the shortcomings of other COVID-19 vaccines. If the efficacy of the BCG vaccine against COVID-19 is confirmed by these clinical trials, the BCG vaccine may be essential to resolve the challenges faced by COVID-19 vaccines.
Topics & Concepts
PandemicMedicineVaccinationCoronavirus disease 2019 (COVID-19)Clinical trialVirologyVaccine efficacySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)ImmunityImmunologyDiseaseInfectious disease (medical specialty)Immune systemPathologyImmune responses and vaccinationsCOVID-19 Impact on ReproductionVaccine Coverage and Hesitancy